Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.-Reference-Cited by-同舟云学术

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Published:1988-08-01 Issue:8 Volume:47 Page:634-641
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Kallenberg C G,Wouda A A,Hoet M H,van Venrooij W J

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference28 articles.

1. Prevalence of primary Raynaud phenomenon in young females;Olsen, N.; L, Nielsen S.;Scand J Clin Lab Invest,1978

2. Prevalence of Raynaud phenomenon in the general population;R, Maricq H.; C, Weinrich M.; E, Keil J.; E, LeRoy C.;J Chronic Dis,1986

3. Systemic sclerosis: a clinical study of 727 cases;L, Tuffanelli D.; K, Winkelmann R.;Arch Dermatol

4. Survival in scleroderma;Bennett, R.; Bluestone, R.; L, Holt P.J.; L, Bywaters E.G.;Ann Rheum Dis,1971

5. Systemic lupus erythematosus in the community;J, Fessel W.;Arch Intern Med,1974

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sekundäres Raynaud-Phänomen;Springer Reference Medizin;2024

2. Associations between nailfold capillary aberrations and autoantibodies in children and adults with Raynaud’s phenomenon;RMD Open;2023-03

3. Predicting progression from undifferentiated connective tissue disease to definite connective tissue disease: A systematic review and meta-analysis;Autoimmunity Reviews;2022-11

4. Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease;Microvascular Research;2022-07

5. The Role of Autoantibody Testing in Modern Personalized Medicine;Clinical Reviews in Allergy & Immunology;2022-03-04